21 and older, any sex, with Vaping Behaviors. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Mean Vaping Quit Intentions ScorePrimary· Up to 4 weeks
The primary outcome is vaping quit intentions measured by 3 survey items at 5 time points: post-labeling (Visit 1) and at 1, 2, 3, and 4 weeks (Visits 2-5). Study investigators will average the items to create a score for each time point and take an average across the time points. The range for this measure will be 1 to 5, with higher values indicating higher quit intentions.
Group
Value
95% CI
Label With Text Health Warning
2.5
± 1.3
Label With Pictorial Health Warning
2.5
± 1.1
Label With Neutral Statements About Vaping
2.2
± 1.0
Mean Knowledge ScoreSecondary· Up to 4 weeks
Knowledge of health harms from vaping will be measured by 5 survey items at 5 time points: post-labeling (Visit 1) and at 1, 2, 3, and 4 weeks (Visits 2-5). Study investigators will score each item for accuracy (correct or incorrect) and average the scores (% correct) for each time point and take an average across the time points. The range for this measure will be 0% to 100%, with higher values indicating more accurate knowledge).
Group
Value
95% CI
Label With Text Health Warning
0.6
± 0.3
Label With Pictorial Health Warning
0.6
± 0.3
Label With Neutral Statements About Vaping
0.4
± 0.3
Mean Cognitive Elaboration ScoreSecondary· Up to 4 weeks
Cognitive elaboration (thinking about the label) will be measured by 3 survey items at 4 time points: 1, 2, 3, and 4 weeks (Visits 2-5). Study investigators will average the items to create a score for each time point and take an average across the time points. The range for this measure will be 1 to 5, with higher values indicating more cognitive elaboration.
Group
Value
95% CI
Label With Text Health Warning
2.7
± 0.9
Label With Pictorial Health Warning
2.9
± 0.9
Label With Neutral Statements About Vaping
2.0
± 0.8
Mean Perceived Likelihood of Illness ScoreSecondary· Up to 4 weeks
Perceived likelihood of illness from vaping will be measured by 3 survey items at 5 time points: post-labeling (Visit 1) and at 1, 2, 3, and 4 weeks (Visit 2-5). Study investigators will average the items to create a score for each time point and take an average across the time points. The range for this measure will be 1 to 5, with higher values indicating higher perceived likelihood.
Group
Value
95% CI
Label With Text Health Warning
3.1
± 0.8
Label With Pictorial Health Warning
3.1
± 0.8
Label With Neutral Statements About Vaping
2.9
± 0.9
Mean Negative Affect ScoreSecondary· Up to 4 weeks
Negative affective reactions to the labels will be measured by 5 survey items at 5 time points: post-labeling (Visit 1) and at 1, 2, 3, and 4 weeks (Visits 2-5). Study investigators will average the items to create a score for each time point and take an average across the time points. The range for this measure will be 1 to 5, with higher values indicating more negative affect.
Group
Value
95% CI
Label With Text Health Warning
2.1
± 0.9
Label With Pictorial Health Warning
2.3
± 1.0
Label With Neutral Statements About Vaping
1.4
± 0.6
Mean Attention ScoreSecondary· Up to 4 weeks
Attention to the labels will be measured by 3 survey items at 4 time points: 1, 2, 3, and 4 weeks (Visits 2-5). Study investigators will average the items to create a score for each time point and take an average across the time points. The range for this measure will be 1 to 5, with higher values indicating greater attention.
Group
Value
95% CI
Label With Text Health Warning
3.1
± 0.9
Label With Pictorial Health Warning
3.3
± 0.9
Label With Neutral Statements About Vaping
2.8
± 0.9
Mean Information Seeking ScoreSecondary· Up to 4 weeks
Information seeking about the harms of vaping will be measured by 1 survey item at 4 time points: 1, 2, 3, and 4 weeks (Visits 2-5). Study investigators will score responses (0 times=0, 1-2 times=1.5, 3-5 times=4, 6+ times=6) and take an average across the time points. The range for this measure will be 0 times to 6 times), with higher values indicating more information seeking.
Group
Value
95% CI
Label With Text Health Warning
1.3
± 1.3
Label With Pictorial Health Warning
1.4
± 1.3
Label With Neutral Statements About Vaping
0.8
± 1.0
Mean Number of Conversations in Past WeekSecondary· Up to 4 weeks
Number of conversations with others about the labels, health harms caused by vaping, and quitting vaping will be measured by 3 survey items at 4 time points: 1, 2, 3, and 4 weeks (Visits 2-5). Study investigators will average the items to create a score for each time point and take an average across the time points. The range for this measure will be 0 times to 100 times, with higher values indicating more conversations.
Group
Value
95% CI
Label With Text Health Warning
1.5
± 2.2
Label With Pictorial Health Warning
1.7
± 2.1
Label With Neutral Statements About Vaping
1.2
± 1.8
Mean Vaping Reinforcement Attitudes ScoreSecondary· Up to 4 weeks
Positive vaping reinforcement attitudes will be measured by 3 survey items at 5 time points: post-labeling (Visit 1) and at 1, 2, 3, and 4 weeks (Visits 2-5). We will take an average across the time points. The range for this measure will be 1 to 5, with higher values indicating more positive vaping reinforcement attitudes.
Group
Value
95% CI
Label With Text Health Warning
4.1
± 0.8
Label With Pictorial Health Warning
4.1
± 0.8
Label With Neutral Statements About Vaping
4.2
± 0.8
Mean Uncontrolled Vaping ScoreSecondary· Up to 4 weeks
Subjective uncontrolled vaping (vaping more than the user prefers) will be measured by 3 survey items at 4 time points: 1, 2, 3, and 4 weeks (Visit 2-5). Study investigators will average the items to create a score for each time point and take an average across the time points. The range for this measure will be 1 to 5, with higher values indicating vaping that is more uncontrolled.
Group
Value
95% CI
Label With Text Health Warning
2.4
± 0.9
Label With Pictorial Health Warning
2.4
± 1.0
Label With Neutral Statements About Vaping
2.3
± 1.0
Mean Number of Times Forgoing a Vape in Past WeekSecondary· Up to 4 weeks
Number of times forgoing a vape in the last week will be measured by 4 survey items at 4 time points: 1, 2, 3, and 4 weeks (Visits 2-5). Study investigators will score responses (never=0, 1 time=1, 2 times=2, 3-5 times=4, 6+ times=6), average the items to create a score for each time point, and take an average across the time points. The range for this measure will be 0 times to 6 times, with higher values indicating more forgoing.
Group
Value
95% CI
Label With Text Health Warning
1.7
± 1.6
Label With Pictorial Health Warning
1.7
± 1.5
Label With Neutral Statements About Vaping
1.3
± 1.4
Percent of Participants Who Made a Vaping Quit Attempt in Past 4 WeeksSecondary· Up to 4 weeks
Made vaping quit attempt will be measured by 1 survey item (not vaping for 1 day or longer in the last week because they were trying to stop vaping) at 4 time points: 1, 2, 3, and 4 weeks (Visits 2-5). There will be an additional item (not vaping for 1 day or longer since the start of the study) at 4 weeks (Visit 5). Study investigators will score the items for any quit attempts: 0 (no quit attempts) or 1 (one or more quit attempt across the 4 weeks).
Group
Value
95% CI
Label With Text Health Warning
217
Label With Pictorial Health Warning
204
Label With Neutral Statements About Vaping
211
Sponsor's own description
The purpose of this randomized clinical trial is to determine whether e-cigarette warnings increase intentions to quit vaping without the unintended consequence of pushing users toward smoking. This trial addresses these issues by evaluating the impact of e-cigarette warnings by randomly assigning vapers to have their devices and refills labeled with control messages, text warnings, or pictorial warnings. Participants will be US adult (ages 21+) vapers. The trial expects \~1,200 participants to complete Visits 1, 3, and 5.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07192601 — Developing an E-Cigarette Cessation Intervention for Hispanic/Latina(o) Youth in Florida: The BReATHE Study
· NA
· active not recruiting
Other UNC Lineberger Comprehensive Cancer Center trials
Trials by the same sponsor.
NCT06656936 — The PharmFIT Study
· NA
· not yet recruiting
NCT05937659 — Incorporating Biometric Data for Patients Receiving Concurrent Chemotherapy & RT
· not yet recruiting
NCT07479199 — Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors
· not yet recruiting
NCT07069595 — PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
· Phase 2
· recruiting
NCT04266730 — Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab
· Phase 1
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by UNC Lineberger Comprehensive Cancer Center
Last refreshed: 12 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05714982.